Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy

Prashanth V. Sreeramoju, Steven K. Libutti

Research output: Book/ReportBook

10 Citations (Scopus)

Abstract

Effective cancer therapy remains a challenge despite recent advances in the identification of novel targets. A major limitation of most chemotherapeutic drugs is their systemic toxicity and the efficacy of cancer treatments is, by and large, determined by the ability to balance their benefits against their toxicity. Targeted treatments for cancer, especially those that target the tumor vasculature, have provided promising antitumor results with minimal systemic toxicity. To date significant progress has been made in developing a variety of delivery systems to target cancer and its vasculature ranging from isolated limb and organ perfusion to tumor targeted biological and nonbiological vectors.

Original languageEnglish (US)
PublisherUnknown Publisher
Number of pages17
Volume69
EditionC
DOIs
StatePublished - 2010

Publication series

NameAdvances in Genetics
No.C
Volume69
ISSN (Print)00652660

Fingerprint

Neoplasms
Therapeutics
Extremities
Perfusion
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Genetics

Cite this

Sreeramoju, P. V., & Libutti, S. K. (2010). Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy. (C ed.) (Advances in Genetics; Vol. 69, No. C). Unknown Publisher. https://doi.org/10.1016/S0065-2660(10)69015-3

Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy. / Sreeramoju, Prashanth V.; Libutti, Steven K.

C ed. Unknown Publisher, 2010. 17 p. (Advances in Genetics; Vol. 69, No. C).

Research output: Book/ReportBook

Sreeramoju, PV & Libutti, SK 2010, Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy. Advances in Genetics, no. C, vol. 69, vol. 69, C edn, Unknown Publisher. https://doi.org/10.1016/S0065-2660(10)69015-3
Sreeramoju, Prashanth V. ; Libutti, Steven K. / Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy. C ed. Unknown Publisher, 2010. 17 p. (Advances in Genetics; C).
@book{2b3bc4357a09434cadff401048bfdb01,
title = "Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy",
abstract = "Effective cancer therapy remains a challenge despite recent advances in the identification of novel targets. A major limitation of most chemotherapeutic drugs is their systemic toxicity and the efficacy of cancer treatments is, by and large, determined by the ability to balance their benefits against their toxicity. Targeted treatments for cancer, especially those that target the tumor vasculature, have provided promising antitumor results with minimal systemic toxicity. To date significant progress has been made in developing a variety of delivery systems to target cancer and its vasculature ranging from isolated limb and organ perfusion to tumor targeted biological and nonbiological vectors.",
author = "Sreeramoju, {Prashanth V.} and Libutti, {Steven K.}",
year = "2010",
doi = "10.1016/S0065-2660(10)69015-3",
language = "English (US)",
volume = "69",
series = "Advances in Genetics",
publisher = "Unknown Publisher",
number = "C",
edition = "C",

}

TY - BOOK

T1 - Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy

AU - Sreeramoju, Prashanth V.

AU - Libutti, Steven K.

PY - 2010

Y1 - 2010

N2 - Effective cancer therapy remains a challenge despite recent advances in the identification of novel targets. A major limitation of most chemotherapeutic drugs is their systemic toxicity and the efficacy of cancer treatments is, by and large, determined by the ability to balance their benefits against their toxicity. Targeted treatments for cancer, especially those that target the tumor vasculature, have provided promising antitumor results with minimal systemic toxicity. To date significant progress has been made in developing a variety of delivery systems to target cancer and its vasculature ranging from isolated limb and organ perfusion to tumor targeted biological and nonbiological vectors.

AB - Effective cancer therapy remains a challenge despite recent advances in the identification of novel targets. A major limitation of most chemotherapeutic drugs is their systemic toxicity and the efficacy of cancer treatments is, by and large, determined by the ability to balance their benefits against their toxicity. Targeted treatments for cancer, especially those that target the tumor vasculature, have provided promising antitumor results with minimal systemic toxicity. To date significant progress has been made in developing a variety of delivery systems to target cancer and its vasculature ranging from isolated limb and organ perfusion to tumor targeted biological and nonbiological vectors.

UR - http://www.scopus.com/inward/record.url?scp=77956149322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956149322&partnerID=8YFLogxK

U2 - 10.1016/S0065-2660(10)69015-3

DO - 10.1016/S0065-2660(10)69015-3

M3 - Book

C2 - 20807606

AN - SCOPUS:77956149322

VL - 69

T3 - Advances in Genetics

BT - Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy

PB - Unknown Publisher

ER -